Biotech Talent Management
An industry of major growth
While many sectors were dealt a severe blow by the COVID-19 pandemic, biotech and medtech saw continued growth and are thus attracting top candidates even for non-scientific roles. According to McKinsey, between January 2020 and January 2021, “the average share price for European and US biotechs increased at more than twice the rate of the S&P 500, and Chinese biotechs performed more than six times better, with their average share price more than doubling in a year.Details see here: Executive Recruiting has changed